Prof. Dr. Valerie Daggett is a Professor of Bioengineering and Adjunct Professor of Biochemistry, Chemical Engineering, and Biomedical and Health Informatics at the University of Washington, Seattle, USA. She is also the Founder and CEO of AltPep, a spinout from her lab at the University of Washington. She completed her PhD at the University of California, San Francisco (1990) and a postdoctoral fellowship at Stanford University in 1993. In 2011, she was named a fellow of the Biophysical Society. She was also named an American Institute for Medical and Biological Engineering fellow in 2015. She currently focuses on protein unfolding and disease, both computational and experimental studies. Her goal is to use the information gleaned from realistic molecular dynamics simulations, particularly the lab's discovery of alpha-sheet structure formed by early amyloidogenic toxic oligomers, for the development of early diagnostics and treatments for amyloid diseases.
Prof. Dr. Valerie Daggett is a Professor of Bioengineering and Adjunct Professor of Biochemistry, Chemical Engineering, and Biomedical and Health Informatics at the University of Washington, Seattle, USA. She is also the Founder and CEO of AltPep, a spinout from her lab at the University of Washington. She completed her PhD at the University of California, San Francisco (1990) and a postdoctoral fellowship at Stanford University in 1993. In 2011, she was named a fellow of the Biophysical Society. She was also named an American Institute for Medical and Biological Engineering fellow in 2015. She currently focuses on protein unfolding and disease, both computational and experimental studies. Her goal is to use the information gleaned from realistic molecular dynamics simulations, particularly the lab's discovery of alpha-sheet structure formed by early amyloidogenic toxic oligomers, for the development of early diagnostics and treatments for amyloid diseases.